Abstract

RIP140 (receptor interacting protein of 140 kDa) is an important player in breast cancer (BC) by regulating key cellular pathways such as nuclear hormone receptors signaling. In order to identify additional genes specifically regulated by RIP140 in BC, we performed an RNA sequencing after silencing its expression in MCF-7 cells. We identified the interferon {gamma} (IFN{gamma}) signaling as being substantially repressed by RIP140 knock-down. Using the GBP1 (guanylate binding protein 1) gene as a reporter of IFN{gamma} signaling, we demonstrated its robust induction by RIP140 through an ISRE motif, leading to a significant reduction of its induction upon IFN{gamma} treatment. Furthermore, we showed that low levels of RIP140 amplified the IFN{gamma}-dependent inhibition of BC cell proliferation. In line with these data, reanalysis of transcriptomic data obtained in human BC samples, revealed that IFN{gamma} levels were associated with good prognosis only for BC patients exhibiting tumors expressing low levels of RIP140, thus confirming its effect on the anti-tumor activity of IFN{gamma} provided by our experimental data. Altogether, this study identifies RIP140 as a new regulator of IFN{gamma} signaling in breast tumorigenesis.